Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder

Overview of attention for article published in Brain, February 2010

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 323 Dimensions

Readers on

mendeley: 186 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Exogenous ketone supplements for reducing anxiety-related behavior

Grant US-11766417-B2

United States of America

Exogenous ketone supplements for reducing anxiety-related behavior

Grant US-10980764-B1

United States of America

Anaplerotic therapy of huntington disease and other polyglutamine diseases

Grant US-10220014-B2

United States of America

Triheptanoin for the treatment of glucose transport 1 deficiency

Grant US-10111848-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.